Increased Thyroid Epithelial Cell Proliferation in Toxic Thyroid Nodules
- 1 March 1999
- journal article
- research article
- Published by Mary Ann Liebert Inc in Thyroid®
- Vol. 9 (3) , 241-246
- https://doi.org/10.1089/thy.1999.9.241
Abstract
Most toxic thyroid nodules (TTN) result from clonal expansion of a single cell caused by a somatic mutation in the thyrotropin (TSH) receptor, the Gsα protein, or yet unknown proteins. Expanding a single cell into a TTN with thousands of cells suggests a prolonged increase in proliferation compared to nonaffected surrounding cells. To test this hypothesis, we evaluated cell proliferation in TTN. Tissue from 20 TTN and their surrounding normal thyroid tissue was studied for the occurrence of the proliferating cell nuclear antigen (PCNA) and Ki-67 epitope as markers for cell proliferation. The labeling index (number of labeled cells versus total cell number) for nodular and surrounding tissue was calculated. Nineteen samples were evaluated for PCNA immunohistochemistry. In 16 TTN, a significant (p ≤ 0.05%) up to 3-fold increase in the labeling index for PCNA was detectable. In only 3 toxic nodules (2 without a detectable TSH receptor or Gsα protein mutation), we found no significant difference in the labeling index compared to the surrounding tissue. Because labeling for KI-67 was much lower, only 16 toxic thyroid nodules were quantified. Twelve of these showed significantly (p ≤ 0.05%) increased labeling indices. The increase of the labeling index for both markers was similar for histologically defined adenoma versus adenomatous nodule or nodules with or without TSH receptor mutation or clonal versus polyclonal origin of toxic nodules studied. These findings are evidence that an increased thyroid epithelial cell proliferation is a uniform feature common to most TTNs, independent of their histopathological or molecular characteristics. Although increased proliferation in many TTNs is very likely the result of TSH receptor mutations, the cause of increased proliferation in TTN without a mutation is unknown.Keywords
This publication has 23 references indexed in Scilit:
- Fibroblast Growth Factors 1 and 2 and Fibroblast Growth Factor Receptor 1 Are Elevated in Thyroid HyperplasiaJournal of Clinical Endocrinology & Metabolism, 1998
- Clonal Origin of Toxic Thyroid Nodules with Constitutively Activating Thyrotropin Receptor MutationsJournal of Clinical Endocrinology & Metabolism, 1998
- An Amphotropic Retroviral Vector Expressing a Mutant gsp Oncogene: Effects on Human Thyroid Cells in VitroJournal of Clinical Endocrinology & Metabolism, 1997
- Expression of functional stimulatory guanine nucleotide binding protein in nonfunctioning thyroid adenomas is not correlated to adenylate cyclase activity and growth of these tumorsJournal of Clinical Endocrinology & Metabolism, 1995
- Expression of Growth Factors and Growth Factor Receptors in Normal and Tumorous Human Thyroid TissuesThyroid®, 1995
- p53 Protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid glandThe Journal of Pathology, 1994
- Enhanced expression of transforming growth factor-β1 during thyroid hyperplasia in ratsJournal of Endocrinology, 1994
- High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East‐Jutland Denmark and IcelandJournal of Internal Medicine, 1991
- The cyclic AMP-mediated stimulation of cell proliferationTrends in Biochemical Sciences, 1989